2m 2m 2m 2m 2m 2m 2m
RAPPORT THERA (RAPP)
NASDAQ
$38.50+$3.60 (+10.31%)
Price as of Jun 03, 2026 5:14 PM EDT- $1.9BMarket Cap
- 185.13%1-Year Change
- BiotechnologyIndustry
RAPPORT THERA (RAPP)
$38.50+$3.60 (+10.31%)
RAPP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $34.90 | ||
Change | -$2.21 (-5.96%) | ||
Open | $36.32 | ||
High | $36.57 | ||
Low | $34.44 | ||
Previous Close | $37.11 | ||
Volume | 309,431 | ||
30-Day Average Volume | 324,662 | ||
1-Week Change | -12.11% | ||
1-Month Change | 2.98% | ||
1-Year Change | 185.13% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 47.8M | ||
Total Assets | $497.6M | ||
Market Cap | $1.9B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$19.9M | ||
Free Cash Flow | -$13.1M | ||
EBIT | -$19.9M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $466.8M | ||
EPS | -$0.42 | ||
Enterprise Value/EBITDA | -92 | ||
Enterprise Value/Revenue | 91 | ||
P/B | 4 | ||
P/E | -94 | ||
PEG | -2 | ||
Price/Free Cash Flow | -144 | ||
Price/Operating Cash Flow | -145 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue